Overexpression of E2F-1 inhibits progression of gastric cancer in vitro

Cell Biology International

Volumn 33, Issue 6, 2009, Pages 640-649

  Xie, Yubo ^a   Wang, Changqing ^a   Li, Lei ^a   Ma, Yulin ^a   Yin, Yongshuo ^a   Xiao, Qiang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

E2F 1; Gastric cancer; MGC 803 cells; Overexpression; Tumor progression

Indexed keywords

TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; STOMACH CARCINOMA;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; HUMANS; STOMACH NEOPLASMS; TRANSFECTION;

EID: 67349181403     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.02.015     Document Type: Article

References (47)

1. Atienza Jr. C., Elliott M.J., Dong Y.B., Yang H.L., Stilwell A., Liu T.J., et al. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Int J Mol Med 6 (2000) 55-63
2. Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwig R.L., et al. p14ARF links the tumour suppressor RB and p53. Nature 395 (1998) 124-125
3. Bell L.A., O'Prey J., and Ryan K.M. DNA-binding independent cell death from a minimal proapoptotic region of E2F-1. Oncogene 25 (2006) 5656-5663
4. Bell L.A., and Ryan K.M. Life and death decisions by E2F-1. Cell Death Differ 11 (2004) 137-142
5. Bracken A.P., Ciro M., Cocito A., and Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci 29 (2004) 409-417
6. Brehm A., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., and Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391 (1998) 597-601
7. Campanero M.R., and Flemington E.K. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci U S A 94 (1997) 2221-2226
8. Cunningham D., Jost L.M., Purkalne G., and Oliveira J. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of gastric cancer. Ann Oncol 16 Suppl. 1 (2005) i22-i23
9. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A 94 (1997) 7245-7250
10. Elliott M.J., Dong Y.B., Yang H., and McMasters K.M. E2F-1 up-regulates c-Myc and p14 (ARF) and induces apoptosis in colon cancer cells. Clin Cancer Res 7 (2001) 3590-3597
11. Evangelou K., Kotsinas A., Mariolis-Sapsakos T., Giannopoulos A., and Tsantoulis P.K. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. J Clin Pathol 61 (2008) 601-605
12. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin Jr. W.G., Livingston D.M., et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85 (1996) 549-561
13. Finzer P., Krueger A., Stohr M., Brenner D., Soto U., Kuntzen C., et al. HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway. Oncogene 23 (2004) 4807-4817
14. Fogal V., Kartasheva N.N., Trigiante G., Llanos S., Yap D., Vousden K.H., et al. ASPP1 and ASPP2 are new transcriptional targets of E2F. Cell Death Differ 12 (2005) 369-376
15. Fueyo J., Gomez-Manzano C., Yung W.K., Liu T.J., Alemany R., McDonnell T.J., et al. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med 4 (1998) 685-690
16. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8 (1998) 28-35
17. Hunt K.K., Deng J., Liu T.J., Wilson-Heiner M., Swisher S.G., Clayman G., et al. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res 57 (1997) 4722-4726
18. Inoue M., and Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J 81 (2005) 419-424
19. Irwin M., Martin M.C., Phillips A.C., Seelan R.S., Smith D.I., Liu W., et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407 (2000) 645-648
20. Ishii H., Mimori K., Vecchione A., Sutheesophon K., Fujiwara T., Mori M., et al. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX. Biochem Biophys Res Commun 316 (2004) 1088-1093
21. Jiang H., Hou C., Zhang S., Xie H., Zhou W., Jin Q., et al. Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol 559 (2007) 98-108
22. Johnson D.G., Cress W.D., Jakoi L., and Nevins J.R. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A 91 (1994) 12823-12827
23. Johnson D.G., Schwarz J.K., Cress W.D., and Nevins J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365 (1993) 349-352
24. Karin M., and Lin A. NF-κB at the crossroads of life and death. Nat Immunol 3 (2002) 221-227
25. Kovesdi R.R., and Nevins J.R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45 (1986) 219-282
26. Kowalik T.F., DeGregori J., Schwarz J.K., and Nevins J.R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 69 (1995) 2491-2500
27. Kuhn H., Liebers U., Gessner C., Schumacher A., Witt C., Schauer J., et al. Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis. Eur Respir J 20 (2002) 703-709
28. La Thangue N.B. The yin and yang of E2F-1: balancing life and death. Nat Cell Biol 5 (2003) 587-589
29. Martelli F., Hamilton T., Silver D.P., Sharpless N.E., Bardeesy N., Rokas M., et al. p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A 98 (2001) 4455-4460
30. Nguyen K.H., Hachem P., Khor L.Y., Salem N., Hunt K.K., Calkins P.R., et al. Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells. Int J Radiat Oncol Biol Phys 63 (2005) 238-246
31. Pierce A.M., Fisher S.M., Conti C.J., and Johnson D.G. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16 (1998) 1267-1276
32. Pierce A.M., Schneider-Broussard R., Gimenez-Conti I.B., Russell J.L., Conti C.J., and Johnson D.G. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol 19 (1999) 6408-6414
33. Suh D.S., Yoon M.S., Choi K.U., and Kim J.Y. Significance of E2F-1 overexpression in epithelial ovarian cancer. Int J Gynecol Cancer 18 (2008) 492-498
34. Suzuki T., Yasui W., Yokozaki H., Naka K., Ishikawa T., and Tahara E. Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer 81 (1999) 535-538
35. Tanaka H., Matsumura I., Ezoe S., Satoh Y., Sakamaki T., Albanese C., et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9 (2002) 1017-1029
36. Vorburger S.A., Hetrakul N., Xia W., Wilson-Heiner M., Mirza N., Pollock R.E., et al. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Mol Cancer Ther 4 (2005) 1710-1716
37. Vorburger S.A., Pataer A., Yoshida K., Barber G.N., Xia W., Chiao P., et al. Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene 21 (2002) 6278-6288
38. Wu J., Jin Y.J., Calaf G.M., Huang W.L., and Yin Y. PAC1 is a direct transcription target of E2F-1 in apoptotic signaling. Oncogene 26 (2004) 6526-6535
39. Xiao Q., Li L., Xie Y., Tan N., Wang C., Xu J., et al. Transcription factor E2F-1 is upregulated in human gastric cancer tissues and its overexpression suppresses gastric tumor cell proliferation. Cell Oncol 4 (2007) 335-349
40. Xu G.D., Livingston M., and Krek W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A 92 (1995) 1357-1361
41. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., and Dyson N.J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85 (1996) 537-548
42. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 12 (2006) 17-20
43. Yang X.H., and Sladek T.L. Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr 4 (1995) 195-204
44. Yasui W., Naka K., Suzuki T., Fujimoto J., Hayashi K., Matsutani N., et al. Expression of p27Kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma. Oncol Rep 6 (1999) 983-987
45. Yasui W., Yokozaki H., Fujimoto J., Naka K., Kuniyasu H., and Tahara E. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 35 (2000) 111-115
46. Yin Y.S., Xiao Q., Xie Y.B., Li L., Wang C.Q., Ma Y.L., et al. Inhibitory effects of transcription factor E2F-1 siRNA on invasion and proliferation of gastric cancer cell line MGC803. Ai Zheng 27 (2008) 914-918
47. Zhang S.Y., Liu S.C., Johnson D.G., and Klein-Szanto A.J. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res 60 (2000) 5972-5976